12814679

Source:http://linkedlifedata.com/resource/pubmed/id/12814679

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036043, umls-concept:C0087111, umls-concept:C0754659, umls-concept:C1554184, umls-concept:C1704272, umls-concept:C1999216, umls-concept:C2252854
pubmed:issue	1
pubmed:dateCreated	2003-6-19
pubmed:abstractText	The objective of this paper is to examine safety and tolerability data from a number of recently completed clinical trials with the novel, dual 5alpha-reductase inhibitor, dutasteride.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/3-Oxo-5-alpha-Steroid..., http://linkedlifedata.com/resource/pubmed/chemical/Azasteroids, http://linkedlifedata.com/resource/pubmed/chemical/dutasteride
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0302-2838
pubmed:author	pubmed-author:AndrioleGerald LGL, pubmed-author:KirbyRogerR
pubmed:issnType	Print
pubmed:volume	44
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	82-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12814679-3-Oxo-5-alpha-Steroid 4-Dehydrogenase, pubmed-meshheading:12814679-Aged, pubmed-meshheading:12814679-Aged, 80 and over, pubmed-meshheading:12814679-Azasteroids, pubmed-meshheading:12814679-Biopsy, Needle, pubmed-meshheading:12814679-Dose-Response Relationship, Drug, pubmed-meshheading:12814679-Double-Blind Method, pubmed-meshheading:12814679-Drug Administration Schedule, pubmed-meshheading:12814679-Drug Interactions, pubmed-meshheading:12814679-Drug Therapy, Combination, pubmed-meshheading:12814679-Follow-Up Studies, pubmed-meshheading:12814679-Humans, pubmed-meshheading:12814679-Male, pubmed-meshheading:12814679-Middle Aged, pubmed-meshheading:12814679-Prostatic Hyperplasia, pubmed-meshheading:12814679-Randomized Controlled Trials as Topic, pubmed-meshheading:12814679-Risk Assessment, pubmed-meshheading:12814679-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia.
pubmed:affiliation	Division of Urologic Surgery, Washington University School of Medicine, 4960 Children's Place, Campus Box 8242, St. Louis, MO 63110, USA. andrioleg@msnotes.wustl.edu
pubmed:publicationType	Journal Article, Comparative Study, Review